Gradient Investments LLC Johnson & Johnson Transaction History

Gradient Investments LLC

$3.78 Billion
Q4 2024

A detailed history of Gradient Investments LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Gradient Investments LLC holds 212,608 shares of JNJ stock, worth $32.3 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

212,608

Previous 225,420 5.68%

Holding current value

$32.3 Million

Previous $36.5 Million 15.83%

% of portfolio

0.81%

Previous 0.96%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$143.34 - $165.86 $1.84 Million - $2.12 Million	-12,812 Reduced 5.68%	212,608 $30.7 Million
Q3 2024 Oct 15, 2024	SELL	$145.48 - $167.38 $1.86 Million - $2.14 Million	-12,788 Reduced 5.37%	225,420 $36.5 Million
Q2 2024 Jul 18, 2024	BUY	$144.38 - $157.78 $2.79 Million - $3.05 Million	19,345 Added 8.84%	238,208 $34.8 Million
Q1 2024 Apr 23, 2024	BUY	$155.22 - $162.74 $282,345 - $296,024	1,819 Added 0.84%	218,863 $34.6 Million
Q4 2023 Jan 18, 2024	BUY	$145.6 - $158.88 $1.4 Million - $1.52 Million	9,597 Added 4.63%	217,044 $34 Million
Q3 2023 Oct 27, 2023	BUY	$155.75 - $174.48 $932,631 - $1.04 Million	5,988 Added 2.97%	207,447 $32.3 Million
Q2 2023 Jul 11, 2023	BUY	$154.35 - $166.11 $2.94 Million - $3.16 Million	19,046 Added 10.44%	201,459 $33.3 Million
Q1 2023 Apr 17, 2023	BUY	$151.05 - $180.26 $6.36 Million - $7.59 Million	42,108 Added 30.01%	182,413 $28.3 Million
Q4 2022 Jan 10, 2023	SELL	$160.2 - $179.79 $91,634 - $102,839	-572 Reduced 0.41%	140,305 $0
Q3 2022 Oct 14, 2022	BUY	$161.33 - $179.52 $1.59 Million - $1.77 Million	9,849 Added 7.52%	140,877 $23 Million
Q2 2022 Jul 11, 2022	SELL	$168.19 - $186.01 $2.17 Million - $2.39 Million	-12,874 Reduced 8.95%	131,028 $23.3 Million
Q1 2022 May 26, 2022	SELL	$158.14 - $179.59 $1.63 Million - $1.85 Million	-10,292 Reduced 6.67%	143,902 $25.5 Million
Q4 2021 Jan 12, 2022	BUY	$155.93 - $173.01 $1.53 Million - $1.7 Million	9,831 Added 6.81%	154,194 $26.4 Million
Q3 2021 Oct 18, 2021	BUY	$161.5 - $179.47 $2.91 Million - $3.23 Million	18,010 Added 14.25%	144,363 $23.3 Million
Q2 2021 Jul 12, 2021	BUY	$159.48 - $171.07 $881,924 - $946,017	5,530 Added 4.58%	126,353 $20.8 Million
Q1 2021 Apr 21, 2021	BUY	$153.07 - $170.48 $1.91 Million - $2.13 Million	12,495 Added 11.53%	120,823 $19.9 Million
Q4 2020 Jan 08, 2021	SELL	$137.11 - $157.38 $145,199 - $166,665	-1,059 Reduced 0.97%	108,328 $16.1 Million
Q3 2020 Oct 06, 2020	BUY	$140.38 - $153.83 $1.56 Million - $1.71 Million	11,103 Added 11.3%	109,387 $16.3 Million
Q2 2020 Jul 10, 2020	SELL	$128.81 - $155.51 $306,310 - $369,802	-2,378 Reduced 2.36%	98,284 $13.8 Million
Q1 2020 Apr 07, 2020	BUY	$111.14 - $153.99 $663,839 - $919,782	5,973 Added 6.31%	100,662 $13.2 Million
Q4 2019 Jan 15, 2020	BUY	$127.5 - $146.44 $574,387 - $659,712	4,505 Added 5.0%	94,689 $13.8 Million
Q3 2019 Oct 10, 2019	BUY	$126.95 - $142.14 $1.01 Million - $1.13 Million	7,939 Added 9.65%	90,184 $11.7 Million
Q2 2019 Jul 16, 2019	BUY	$131.15 - $144.24 $2.43 Million - $2.68 Million	18,556 Added 29.14%	82,245 $11.5 Million
Q1 2019 Apr 11, 2019	SELL	$125.72 - $139.79 $825,100 - $917,441	-6,563 Reduced 9.34%	63,689 $8.9 Million
Q4 2018 Jan 18, 2019	SELL	$122.84 - $147.84 $607,689 - $731,364	-4,947 Reduced 6.58%	70,252 $9.07 Million
Q3 2018 Oct 11, 2018	BUY	$121.58 - $142.88 $455,925 - $535,800	3,750 Added 5.25%	75,199 $10.4 Million
Q2 2018 Aug 09, 2018	BUY	$119.4 - $131.76 $518,076 - $571,706	4,339 Added 6.47%	71,449 $8.67 Million
Q1 2018 Apr 11, 2018	BUY	$125.1 - $148.14 $729,958 - $864,396	5,835 Added 9.52%	67,110 $8.6 Million
Q4 2017 Feb 07, 2018	BUY	$131.22 - $143.62 $384,868 - $421,237	2,933 Added 5.03%	61,275 $8.56 Million
Q3 2017 Oct 16, 2017	BUY	$129.47 - $135.38 $7.55 Million - $7.9 Million	58,342	58,342 $7.59 Million

Others Institutions Holding JNJ

# of Institutions

4,312

Shares Held

1.68B

Call Options Held

17.7M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $398B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account

Gradient Investments LLC Johnson & Johnson Transaction History